Umbilical cord-derived mesenchymal stromal cell therapy to prevent the development of neurodevelopmental disorders related to low birth weight
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Umbilical cord-derived mesenchymal stromal cell therapy to prevent the development of neurodevelopmental disorders related to low birth weight ; volume:13 ; number:1 ; day:7 ; month:3 ; year:2023 ; pages:1-16 ; date:12.2023
Scientific reports ; 13, Heft 1 (7.3.2023), 1-16, 12.2023
- Creator
-
Tsuji, Masahiro
Mukai, Takeo
Sato, Yoshiaki
Azuma, Yasue
Yamamoto, Saki
Cayetanot, Florence
Bodineau, Laurence
Onoda, Atsuto
Nagamura-Inoue, Tokiko
Coq, Jacques-Olivier
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-30817-3
- URN
-
urn:nbn:de:101:1-2410301029210.674960027925
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsuji, Masahiro
- Mukai, Takeo
- Sato, Yoshiaki
- Azuma, Yasue
- Yamamoto, Saki
- Cayetanot, Florence
- Bodineau, Laurence
- Onoda, Atsuto
- Nagamura-Inoue, Tokiko
- Coq, Jacques-Olivier
- SpringerLink (Online service)
Other Objects (12)
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis
Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells
Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Human umbilical cord-derived mesenchymal stem cells utilise activin-A to suppress interferon-gamma production by natural killer cells
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells
Large-scale expansion of human umbilical cord-derived mesenchymal stem cells using PLGAPLL scaffold
Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis
Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells
Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Human umbilical cord-derived mesenchymal stem cells utilise activin-A to suppress interferon-gamma production by natural killer cells
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells
Large-scale expansion of human umbilical cord-derived mesenchymal stem cells using PLGAPLL scaffold
Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis
Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells
Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Human umbilical cord-derived mesenchymal stem cells utilise activin-A to suppress interferon-gamma production by natural killer cells
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells
Large-scale expansion of human umbilical cord-derived mesenchymal stem cells using PLGAPLL scaffold